nach oben

Erschienen in:

01.08.2011 | Topic paper

Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer

verfasst von: Mario W. Kramer, Thorsten Bach, Mathias Wolters, Florian Imkamp, Andreas J. Gross, Markus A. Kuczyk, Axel S. Merseburger, Thomas R. W. Herrmann

Erschienen in: World Journal of Urology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Bladder cancer is the second most common malignancy of urologic tumors. Back in 1976, lasers were added to the endourological armetarium for bladder tumor treatment. Despite nowadays’ standard procedure for staging and treating non-muscle invasive bladder tumor by transurethral resection of bladder tumors (TURB) via a wire loop, laser resection techniques for bladder tumor came back in focus with the introduction of Ho:YAG and not to mention recently Tm:YAG lasers. This review aims to display the current evidence for these techniques.

Materials and methods

Throughout April 2010, MEDLINE and the Cochrane central register of controlled trials were searched previously for the following terms: “Laser, resection, ablation, coagulation, Nd:YAG Neodym, HoYAG: Holmium, Tm:YAG Thulium and transitional carcinoma, bladder, intravesical.”

Results

Eleven articles on Ho:YAG and 7 on Tm:YAG were identified. Searches by Cochrane online library resulted in no available manuscripts.

Conclusion

Today, Nd:YAG does not play any role in treatment of lower urinary tract transitional cell carcinoma. Ho:YAG and Tm:YAG seem to offer alternatives in the treatment of bladder cancer, but still to prove their potential in larger prospective randomized controlled studies with long-term follow-up. Future expectations will show whether en bloc resection of tumors are preferable to the traditional “incise and scatter” resection technique, in which is contrary to all oncological surgical principles. For the primary targets, here are within first-time clearance of disease, in addition to low in-fields and out-of-fields recurrence rates.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59(4):225–249. doi:10.3322/caac.20006 PubMedCrossRef

Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27(3):289–293. doi:10.1007/s00345-009-0383-3 PubMedCrossRef

Bach THT, Netsch C, Haecker A, Michel MS, Gross AJ (2010) Vapoenucleation of the prostate using the thulium:YAG 2 micron cw laser in high-risk patients. J Urol 183(4 Supplement):e745–e746CrossRef

Kuo RL, Aslan P, Fitzgerald KB, Preminger GM (1998) Use of ureteroscopy and holmium:YAG laser in patients with bleeding diatheses. Urology 52(4):609–613PubMedCrossRef

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE (2005) Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19(10):1196–1198. doi:10.1089/end.2005.19.1196 PubMedCrossRef

Turrentine FE, Wang H, Simpson VB, Jones RS (2006) Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg 203(6):865–877. doi:10.1016/j.jamcollsurg.2006.08.026 PubMedCrossRef

Gross AJ, Herrmann TR (2007) History of lasers. World J Urol 25(3):217–220. doi:10.1007/s00345-007-0173-8 PubMedCrossRef

Staehler G, Schmiedt E, Hofstetter A (1978) Destruction of bladder neoplasms by means of transurethral neodym-YAG-laser coagulation. Helv Chir Acta 45(3):307–311PubMed

Kuntz RM (2006) Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 49(6):961–969. doi:10.1016/j.eururo.2006.03.028 PubMedCrossRef

10.

Pietrow PK, Smith JA Jr (2001) Laser treatment for invasive and noninvasive carcinoma of the bladder. J Endourol 15(4):415–418. doi:10.1089/089277901300189466 discussion 425–416PubMedCrossRef

11.

Beer M, Jocham D, Beer A, Staehler G (1989) Adjuvant laser treatment of bladder cancer: 8 years’ experience with the Nd-YAG laser 1064 nm. Br J Urol 63(5):476–478PubMedCrossRef

12.

Cos LR, Di Sant’agnese PA (1988) ND: YAG nomogram dosimetry scale for the bladder. J Urol 139(1):196–198PubMed

13.

Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225. doi:10.1007/s00345-007-0184-5 PubMedCrossRef

14.

Yarborough JM (1996) Taking the confusion out of matching medical lasers. Lasers and Laser Systems. Medical Lasers. The photonics design and application handbook, pp H287–H290

15.

Johnson DE, Cromeens DM, Price RE (1992) Use of the holmium:YAG laser in urology. Lasers Surg Med 12(4):353–363PubMedCrossRef

16.

Kuntz RM (2007) Laser treatment of benign prostatic hyperplasia. World J Urol 25(3):241–247. doi:10.1007/s00345-007-0170-y PubMedCrossRef

17.

Teichman JM (2002) Laser lithotripsy. Curr Opin Urol 12(4):305–309PubMedCrossRef

18.

Pierre S, Preminger GM (2007) Holmium laser for stone management. World J Urol 25(3):235–239. doi:10.1007/s00345-007-0162-y PubMedCrossRef

19.

Xia SJ, Zhang YN, Lu J, Sun XW, Zhang J, Zhu YY, Li WG (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Zhonghua Yi Xue Za Zhi 85(45):3225–3228PubMed

20.

Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19(1):25–31. doi:10.1089/end.2005.19.25 PubMedCrossRef

21.

Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51. doi:10.1007/s00345-009-0503-0 PubMedCrossRef

22.

Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545. doi:10.1007/s00345-008-0370-0 PubMedCrossRef

23.

Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Hacker A (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5):1041–1045. doi:10.1089/end.2007.0421 PubMedCrossRef

24.

Fried NM (2005) High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 microm. Lasers Surg Med 36(1):52–56. doi:10.1002/lsm.20126 PubMedCrossRef

25.

Bach T, Huck N, Wezel F, Hacker A, Gross AJ, Michel MS (2010) 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex vivo evaluation. BJU Int 106(3):368–372. doi:10.1111/j.1464-410X.2009.09059.x PubMedCrossRef

26.

Wezel F, Wendt-Nordahl G, Huck N, Bach T, Weiss C, Michel MS, Hacker A (2010) New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1, 318- and 1, 470-nm diode laser device. World J Urol 28(2):181–186. doi:10.1007/s00345-009-0499-5 PubMedCrossRef

27.

Heinrich E, Wendt-Nordahl G, Honeck P, Alken P, Knoll T, Michel MS, Häcker A (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24(1):75–79

28.

Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25(3):257–262. doi:10.1007/s00345-007-0171-x PubMedCrossRef

29.

Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39–43. doi:10.1007/s00345-009-0461-6 PubMedCrossRef

30.

Bach T, Xia SJ, Yang Y, Mattioli S, Watson GM, Gross AJ, Herrmann TR (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168. doi:10.1007/s00345-010-0522-x PubMedCrossRef

31.

Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M (2009) Laser treatments of the prostate vs TURP/open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol 61(3):309–324PubMed

32.

Guo FF, Lu H, Wang GJ, Tan SF, He XF, Wang JM, Liu HJ, Zhu WB (2010) Transurethral 2-microm laser in the treatment of urethral stricture. World J Urol 28(2):173–175. doi:10.1007/s00345-009-0454-5 PubMedCrossRef

33.

Bach T, Herrmann TR, Cellarius C, Gross AJ (2007) Bladder neck incision using a 70 W 2 micron continuous wave laser (RevoLix). World J Urol 25(3):263–267. doi:10.1007/s00345-007-0169-4 PubMedCrossRef

34.

Scoffone CM, Cracco CM, Poggio M, Cossu M, Scarpa RM (2008) Treatment of the pyelocalyceal tumors with laser. Arch Esp Urol 61(9):1080–1087PubMedCrossRef

35.

Gruschwitz T, Stein R, Schubert J, Wunderlich H (2008) Laser-supported partial nephrectomy for renal cell carcinoma. Urology 71(2):334–336. doi:10.1016/j.urology.2007.09.060 PubMedCrossRef

36.

Boylu U, Oommen M, Joshi V, Thomas R, Lee BR (2010) Natural orifice translumenal endoscopic surgery (NOTES) partial nephrectomy in a porcine model. Surg Endosc 24(2):485–489. doi:10.1007/s00464-009-0610-4 PubMedCrossRef

37.

Gao X, Ren S, Xu C, Sun Y (2008) Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int 102(9):1115–1118. doi:10.1111/j.1464-410X.2008.07814.x PubMedCrossRef

38.

Johnson DE (1994) Use of the holmium:YAG (Ho:YAG) laser for treatment of superficial bladder carcinoma. Lasers Surg Med 14(3):213–218PubMedCrossRef

39.

Das A, Gilling P, Fraundorfer M (1998) Holmium laser resection of bladder tumors (HoLRBT). Tech Urol 4(1):12–14PubMed

40.

Razvi HA, Chun SS, Denstedt JD, Sales JL (1995) Soft-tissue applications of the holmium:YAG laser in urology. J Endourol 9(5):387–390PubMedCrossRef

41.

Syed HA, Biyani CS, Bryan N, Brough SJ, Powell CS (2001) Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience. J Endourol 15(6):625–627. doi:10.1089/089277901750426427 PubMedCrossRef

42.

Jonler M, Lund L, Bisballe S (2004) Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. BJU Int 94(3):322–325. doi:10.1111/j.1464-410X.2004.04882.x PubMedCrossRef

43.

Hossain MZ, Khan SA, Salam MA, Hossain S, Islam R (2005) Holmium YAG laser treatment of superficial bladder carcinoma. Mymensingh Med J 14(1):13–15PubMed

44.

Kawada T, Ebihara K, Suzuki T, Imai K, Yamanaka H (1997) A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 157(6):2225–2226PubMedCrossRef

45.

Ukai R, Kawashita E, Ikeda H (2000) A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol 163(3):878–879PubMedCrossRef

46.

Saito S (2001) Transurethral en bloc resection of bladder tumors. J Urol 166(6):2148–2150PubMedCrossRef

47.

Gilling PJ, Cass CB, Cresswell MD, Fraundorfer MR (1996) Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 47(1):48–51PubMedCrossRef

48.

Muraro GB, Grifoni R, Spazzafumo L (2005) Endoscopic therapy of superficial bladder cancer in high-risk patients: holmium laser versus transurethral resection. Surg Technol Int 14:222–226PubMed

49.

Soler-Martinez J, Vozmediano-Chicharro R, Morales-Jimenez P, Hernandez-Alcaraz D, Vivas-Vargas E, Santos Garcia-Vaquero I, Baena-Gonzalez V (2007) Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. J Urol 178(6):2337–2339. doi:10.1016/j.juro.2007.08.034 PubMedCrossRef

50.

Zhu Y, Jiang X, Zhang J, Chen W, Shi B, Xu Z (2008) Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 72(3):608–612. doi:10.1016/j.urology.2008.05.028 PubMedCrossRef

51.

Xishuang S, Deyong Y, Xiangyu C, Tao J, Quanlin L, Hongwei G, Jibin Y, Dongjun W, Zhongzhou H, Jianbo W, Lina W, Lin Y (2010) Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 24(1):69–73. doi:10.1089/end.2009.0171 PubMedCrossRef

52.

Guo G, Yang Y, Hong BF, Zhang X, Zhou ZH (2009) Histopathologic analysis of 2 micron continuous wave laser for the partial cystectomy of bladder urothelial carcinoma. Zhonghua Wai Ke Za Zhi 47(20):1566–1568PubMed

53.

Wei ZT, Xu Y, Xu F, Yang Y, Guo G, Hong BF, Zhang X (2010) Transurethral partial cystectomy using a 2 microm continuous wave laser in treatment of bladder carcinoma: 1-year follow-up. Zhonghua Wai Ke Za Zhi 48(3):221–223PubMed

54.

Yang Y, Wei ZT, Zhang X, Hong BF, Guo G (2009) Initial experience of partial cystectomy in treatment of bladder tumor by 2 microm continuous wave laser. Zhonghua Wai Ke Za Zhi 47(2):143–145PubMed

55.

Yang Y, Wei ZT, Zhang X, Hong BF, Guo G (2009) Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol 182(1):66–69. doi:10.1016/j.juro.2009.02.154 PubMedCrossRef

56.

Zhong C, Guo S, Tang Y, Xia S (2010) Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol 28(2):157–161. doi:10.1007/s00345-010-0532-8 PubMedCrossRef

57.

Wolters M, Kramer MW, Becker JU, Christgen M, Nagele U, Imkamp F, Burchardt MS, Merseburger AS, Kuczyk MA, Bach T, Gross AJ, Herrmann TRW (2011) Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. doi:10.1007/s00345-011-0686-z

58.

Collado A, Chechile GE, Salvador J, Vicente J (2000) Early complications of endoscopic treatment for superficial bladder tumors. J Urol 164(5):1529–1532PubMedCrossRef

59.

Dick A, Barnes R, Hadley H, Bergman RT, Ninan CA (1980) Complications of transurethral resection of bladder tumors: prevention, recognition and treatment. J Urol 124(6):810–811PubMed

60.

Kondas J, Szentgyorgyi E (1992) Transurethral resection of 1250 bladder tumours. Int Urol Nephrol 24(1):35–42PubMedCrossRef

61.

Nieder AM, Meinbach DS, Kim SS, Soloway MS (2005) Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 174(6):2307–2309. doi:10.1097/01.ju.0000181797.19395.03 PubMedCrossRef

62.

Pycha A, Lodde M, Lusuardi L, Palermo S, Signorello D, Galantini A, Mian C, Hohenfellner R (2003) Teaching transurethral resection of the bladder: still a challenge? Urology 62(1):46–48PubMedCrossRef

63.

Wilby D, Thomas K, Ray E, Chappell B, O’Brien T (2009) Bladder cancer: new TUR techniques. World J Urol 27(3):309–312. doi:10.1007/s00345-009-0398-9 PubMedCrossRef

64.

Nagele U, Kugler M, Nicklas A, Merseburger AS, Walcher U, Mikuz G, Herrmann TR (2011) Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol doi:10.1007/s00345-011-0653-8

65.

Elzayat E, Habib E, Elhilali M (2006) Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 175(4):1428–1432. doi:10.1016/S0022-5347(05)00645-2 PubMedCrossRef

Titel: Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer
verfasst von: Mario W. Kramer
Thorsten Bach
Mathias Wolters
Florian Imkamp
Andreas J. Gross
Markus A. Kuczyk
Axel S. Merseburger
Thomas R. W. Herrmann
Publikationsdatum: 01.08.2011
Verlag: Springer-Verlag
Erschienen in: World Journal of Urology / Ausgabe 4/2011
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-011-0680-5

Neu im Fachgebiet Urologie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer

Abstract

Introduction

Materials and methods

Results

Conclusion

Neu im Fachgebiet Urologie

Hochrisiko-Eingriffe für postoperative Übelkeit

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

TURP hat Vorteile im Vergleich mit der Embolisation

Update Urologie

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Gender effect on renal outcome in patients with urothelial carcinoma

Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate

Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?

External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

Predictive factors of recurrence and survival of upper tract urothelial carcinomas

No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time

Neu im Fachgebiet Urologie

Hochrisiko-Eingriffe für postoperative Übelkeit

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

TURP hat Vorteile im Vergleich mit der Embolisation

Update Urologie